Lesson plan
Obocell
Obocell is the brand name of a CNS stimulant and appetite suppressant (d-amphetamine phosphate) combined into one pill with a CNS depressant and first generation antihistamine (25mg methapyrilene). This combination formula was developed by Neisler Laboratories in 1951, approved for medical use in the United States by the U.S. Food and Drug Administration in 1953 to treat obesity. According to the National Institutes of Health, production or availability of Obocell was discontinued around 1967. It was approved for medical use in the U.S. in 1953, and available for over the counter sales between 1953 and 1967, in the dosage form of a tablet, and indicated for treating obesity in patients by functioning as an appetite suppressant.
Article summary
Obocell is the brand name of a CNS stimulant and appetite suppressant (d-amphetamine phosphate) combined into one pill with a CNS depressant and first generation antihistamine (25mg methapyrilene). This combination formula was developed by Neisler Laboratories in 1951, approved for medical use in the United States by the U.S. Food and Drug Administration in 1953 to treat obesity. According to the National Institutes of Health, production or availability of Obocell was discontinued around 1967. It was approved for medical use in the U.S. in 1953, and available for over the counter sales between 1953 and 1967, in the dosage form of a tablet, and indicated for treating obesity in patients by functioning as an appetite suppressant.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.